AGP Executive Report
Last update: an hour agoCannabis Policy Fight: Anti-marijuana groups and a cannabis biopharma company filed a fresh brief to block a Trump hemp CBD Medicare coverage plan, arguing the program is harmful and that they should have standing. Medical Cannabis Market: SOMAÍ launched its Soma OG medical cannabis flower brand in Switzerland via Dascoli Pharma AG, adding three indoor cultivars to a regulated supply chain. Corporate Moves in Cannabis: Curaleaf reiterated its push for Aurora Cannabis with an updated offer around $5/share and expanded supply terms, while Aurora’s response keeps the hostile bid in play. International Expansion: A Salmon Arm cannabis processor is seeking zoning changes to expand its facility as it targets European, Australian and UK markets under GMP. Hemp Industry Watch: IND HEMP invested in new fiber processing equipment in Montana to bring spinnable-quality hemp fiber in-house for global textile demand. Enforcement & Courts: UK-linked EncroChat cases continue in Northern Ireland, with men jailed over cannabis and cocaine trafficking tied to encrypted-phone investigations. Public Health & Youth Safety: MADD Canada and Manitoba Public Insurance kicked off a school tour warning that alcohol and cannabis (and other drugs) are involved in more than half of youth crashes. Business Finance: Safe Harbor reported preliminary Q3 deposit figures, showing deposit growth tied to regulated cannabis and hemp banking demand.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
